This online, on-demand virtual symposium brings together experts in the treatment of presbyopia. The use of topical therapies for presbyopia requires careful consideration of mechanisms of action, durability of effect, and potential risks. In this program, the expert faculty who compare characteristics of approved and emerging topical therapies and provide insights into identifying appropriate patients and providing education to help them optimize their use. This educational activity is an archive of the live virtual symposium held on May 2, 2026.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
100% of listed courses are free
272 of 272 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Gynecologic Oncology
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Infectious Disease
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Neurosurgery
- Nuclear Medicine
- Ophthalmology
- Pediatric Hematology-Oncology
- Psychotic Disorders
- Pulmonary Disease
- Radiation Oncology
- Rheumatology
- Surgical Oncology
- Urological Oncology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
- On-demand / recorded video
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedMay 29, 2026
-
Last day to claim creditMay 30, 2027 8 months left
-
Medical Letter, The 1741: New Drugs for Presbyopia, UTI, and Hereditary Angioedema
-
PRIME Education, Inc. (PRIME®) Focus Reengineered: Mechanisms and Clinical Data for Pharmacologic Presbyopia Therapies
-
PRIME Education, Inc. (PRIME®) Focus Aligned: Patient Selection and Counseling for Pharmacologic Presbyopia Therapies
-
Physicians’ Education Resource (CME Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management
-
Physicians’ Education Resource (CME) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights
-
Physicians’ Education Resource (CME Track) Emerging Therapeutic Advancements in Dry Eye Disease Management
